PolyXen 平台 :PolyXen是蛋白质和肽药物输送的使能平台技术。它使用生物聚合物聚唾液酸(PSA)来延长药物的半衰期,并可能提高治疗肽和蛋白质的稳定性。附着部位和PSA链的长度都可以通过改变分子的表观流体力学半径来影...查看全文
牛股小红书2022-04-28 13:48
$Xenetic Biosciences(XBIO)$ 与CLS Therapeutics签署了独家许可和再许可协议,以开发其基于DNA酶的介入性肿瘤学平台,旨在改善现有治疗,包括免疫疗法。
根据协议,Xenetic拥有CLS知识产权的独家许可证,用于在癌症中使用DNA酶,包括DNA酶与标准疗法(包括化疗、放疗和检查点抑制剂)的系统联...查看全文
$Xenetic Biosciences(XBIO)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-07-19 AccNo: 0001683168-19-002248 Size: 1 MB 网页链接
$Xenetic Biosciences(XBIO)$ D - Notice of Exempt Offering of Securities Filed: 2019-07-18 AccNo: 0001683168-19-002236 Size: 11 KB 网页链接
$Xenetic Biosciences(XBIO)$ EFFECT - Notice of Effectiveness Filed: 2019-07-16 AccNo: 9999999995-19-001611 Size: 1 KB 网页链接
$Xenetic Biosciences(XBIO)$ 8-K - Current report Filed: 2019-07-17 AccNo: 0001683168-19-002217 Size: 45 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Xenetic Biosciences(XBIO)$ 8-K - Current report Filed: 2019-07-16 AccNo: 0001683168-19-002214 Size: 92 KBItem 9.01: Financial Statements and Exhibits 网页链接
$Xenetic Biosciences(XBIO)$ 8-K - Current report Filed: 2019-07-16 AccNo: 0001683168-19-002198 Size: 46 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Xenetic Biosciences(XBIO)$ S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933 Filed: 2019-07-12 AccNo: 0001683168-19-002183 Size: 1 MB 网页链接
$Xenetic Biosciences(XBIO)$ S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933 Filed: 2019-07-05 AccNo: 0001683168-19-002118 Size: 1 MB 网页链接
$Xenetic Biosciences(XBIO)$ 8-K - Current report Filed: 2019-07-02 AccNo: 0001683168-19-002076 Size: 19 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 网页链接
$Xenetic Biosciences(XBIO)$ S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933 Filed: 2019-07-02 AccNo: 0001683168-19-002077 Size: 5 MB 网页链接